FindTrial
Sign In

Effect of aftimoon hindi in the management of menopausal transition

Study of the efficacy of aftimoon hindi in the management of menopausal transition - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083763
Enrollment
50
Registered
2025-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

Intervention1: Aftimoon hindi (cuscuta reflexa roxb): The above drug is cleaned and then grinded into fine powder enroll patient will be given 3gms daily with milk at bedtime for 15days for 3months Co

Sponsors

Government Nizamia Tibbi College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.woman having amenorrhea for more than 60 days. 2.presence of any of these symptoms like: - Hot flashes - palpitations - sleep disturbances - night sweats - anxiety - depression

Exclusion criteria

Exclusion criteria: 1.excessive vaginal bleeding. 2.patient with known endocrine diseases a d malignancy. 3.patient with history of HRT within 2 months.

Design outcomes

Primary

MeasureTime frame
Total score of MRSTimepoint: 12 weeks—

Secondary

MeasureTime frame
Include menopausal rating scale & severity of symptomsTimepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr Syeda Abidunnisa

Government Nizamia Tibbi College and General Hospital

Syedaabidunnisa@gmail.com9492027082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026